Video game developer and publisher Ubisoft (UBSFY) has delayed the release of Assassin’s Creed Shadows again. The company cites needing extra time to respond to fan feedback for the delay. That makes sense as reception leading up to the game’s release has been negative. This also marks the second time the game has been delayed due to fan backlash.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
That has Ubisoft targeting a March 20, 2025 release date for Assassin’s Creed Shadows, giving the developer an extra month to integrate fan feedback. However, this might not be the only reason Ubisoft has delayed Assassin’s Creed Shadows’ release. The company may have done so to avoid a conflict with other games coming out in February.
Monster Hunter Wilds Launches in February
Monster Hunter Wilds, the latest game in Capcom’s (CCOEY) long-running series about fighting large creatures with friends or solo, is coming out on February 28, 2025. It seems likely that Ubisoft doesn’t want to directly compete with the game. That’s despite the Assassin’s Creed series having sold more than 200 million units as of September 2022, as compared to Monster Hunter’s 100 million unit sales reached in May 2024.
While Assassin’s Creed may be the bigger series, Monster Hunter and other Capcom titles have grown immensely in the last few years. At the same time, Ubisoft franchises, Assassin’s Creed included, have started to suffer from player fatigue and other issues.
Rumors have also been swirling that Ubisoft is trying to avoid bankruptcy this year. If that’s true, the studio would likely prefer to avoid Assassin’s Creed Shadows competing against Monster Hunter Wilds. Doing so could harm the game’s sales and put additional financial strain on the company, which is $2.34 billion in debt.
Ubisoft vs Capcom: Which Stock is Better?
Turning to Wall Street, there’s not much analyst coverage for these two stocks. Instead, investors will want to compare the stocks’ performance over the last few years to weigh potential investments in them. The chart below doesn’t look good for UBSFY shares with an 82.64% drop in the previous five years versus a 212.61% gain for CCOEY stock during that same period.
